Weight Management Devices Market Size and Share - Growth Analysis Report and Forecast Trends 2026-2030

The Weight Management Devices Market covers a spectrum of products and technologies aimed at supporting weight loss and long-term weight control. This includes minimally invasive medical devices (such as intragastric balloon systems and gastric emptying devices), wearable fitness and biosensor technologies, digital health platforms, and exercise equipment. The broader weight management market was estimated at approximately $142.58 billion in 2022 and is projected to grow substantially through 2030 at a CAGR of nearly 10%, while the devices-specific segment alone is expected to contribute tens of billions in annual revenue by the end of the decade.

• •Broader market valued at ~$191.53 billion in 2024, projected to $210.88 billion in 2025 with ~10% CAGR through 2035
• •Devices segment valued at ~$13.42 billion in 2025, with sub-sector projections reaching ~$52.2 billion by 2030
• •Complements the non-device segment (supplements, services, digital apps) that together form the broader $298+ billion market by 2030

Escalating global obesity rates remain the single largest catalyst, with rising body mass index trends across both developed and emerging economies driving demand for both clinical and consumer-facing weight management solutions. Growing awareness of the health risks associated with obesity, including diabetes, cardiovascular disease, and metabolic syndrome, has expanded the addressable market. Advances in minimally invasive and digital health technologies are also broadening the range of accessible, non-surgical options available to patients and consumers.

• •Rising global obesity prevalence and associated chronic disease burden expanding the patient pool
• •Increasing clinical and consumer preference for minimally invasive and non-surgical weight loss interventions
• •Digital health integration and wearable sensor technologies creating new product categories and use cases

The market is broadly segmented into device-based solutions (medical and consumer) and non-device offerings (supplements, meal replacements, digital platforms, and fitness services). Device categories further include gastric balloon systems, gastrointestinal devices, wearable fitness trackers, and body composition monitors. Geographically, North America, Europe, and China collectively account for approximately 70% of the market, with North America typically leading in both market value and innovation adoption due to higher obesity prevalence and healthcare spending per capita.

• •Key product segments: minimally invasive medical devices, wearables/biosensors, digital health apps, and fitness equipment
• •North America, Europe, and China combined hold ~70% of global market share
• •Devices segment projected to reach ~$52.2 billion by 2030 at a 3.9% CAGR

Who are the notable companies in the industry?

The competitive structure spans a range of integrated healthcare conglomerates and focused specialty device producers. The market exhibits moderate fragmentation, with no single producer dominating the entire value chain. Integrated manufacturers leverage broader medical device or pharmaceutical portfolios to cross-sell into weight management, while specialty firms concentrate on niche device categories. Production routes vary by product type, encompassing precision-engineered medical devices, digital hardware (wearables and sensors), and software platforms. Capacity is concentrated in established medical device manufacturing hubs, with North American and European facilities dominating high-complexity device production and Asia-Pacific facilities serving a growing share of component and finished-device output.

• •Moderately fragmented market with a mix of diversified integrated healthcare producers and focused specialty device manufacturers
• •Technology routes span minimally invasive medical devices, wearable biosensors, and integrated software/digital platforms
• •Manufacturing and R&D capacity concentrated in North America and Europe, with growing Asia-Pacific production footprint

What are the recent trends and outlook?

The market is expected to sustain robust growth momentum through 2030 and beyond, with device-specific revenue expanding alongside the broader weight management ecosystem. Key trends include the convergence of hardware devices with AI-driven digital platforms for personalized weight management, increasing regulatory approvals for novel minimally invasive devices, and rising healthcare provider referrals to clinically validated weight management programs. The sector is positioned to benefit from long-term demographic and lifestyle shifts, with projections suggesting the devices segment alone could add over $126 billion in cumulative revenue from 2026 through 2030.

• •AI and digital platform integration with physical devices driving personalized, connected weight management solutions
• •Growing pipeline of regulatory-approved minimally invasive medical devices expanding clinical treatment options
• •Long-term outlook remains strongly positive with projected cumulative devices segment growth of ~$126 billion over 2026-2030